See All Slides - tctmd.com

Slides

Presentation TCT 2013

How the Cardiologist Can Help in Stroke Prevention

Presenter: Leo Nelson Hopkins

October 31, 2013

Presentation TCT 2013

Case #1 - Multivessel Disease: Who Should Choose the Therapy?

Presenter: Chris Zambakides

October 31, 2013

Presentation TCT 2013

How Would I Treat this Patient?(10)

Presenter: Vjekoslav Tomulic

October 31, 2013

Presentation TCT 2013

Cangrelor Will Be the Answer for Most in the Acute Setting!

Presenter: Robert Harrington

October 31, 2013

Presentation TCT 2013

Technical Mastery of Left Main PCI: The Do's and The Don'ts

Presenter: Andrejs Erglis

October 31, 2013

Presentation TCT 2013

Fish Oil and CHD Benefit: Is It the Dose, Type, Genetics or Blood Level? (EPA, DHA, FADS)

Presenter: H. Robert Superko

October 31, 2013

Presentation TCT 2013

Renal Denervation with the St. Jude EnligHTN Device: One Simple and One Not-So-Simple Case

Presenter: Felix Mahfoud

October 31, 2013

Presentation TCT 2013

Case #4: Left Main CTO in Cardiogenic Shock

Presenter: Kais Battikh

October 31, 2013

Presentation TCT 2013

Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection

Presenter: Praveen Chandra

October 31, 2013

Presentation TCT 2013

Featured Trial of the Day: OPTIMIZE: A Prospective, Randomized Trial of Three Months vs. 12 Months of Dual Antiplatelet Therapy After PCI

Presenter: Fausto Feres

October 31, 2013

Advertisement

Slides

How the Cardiologist Can Help in Stroke Prevention

Case #1 - Multivessel Disease: Who Should Choose the Therapy?

How Would I Treat this Patient?(10)

Cangrelor Will Be the Answer for Most in the Acute Setting!

Technical Mastery of Left Main PCI: The Do's and The Don'ts

Fish Oil and CHD Benefit: Is It the Dose, Type, Genetics or Blood Level? (EPA, DHA, FADS)

Renal Denervation with the St. Jude EnligHTN Device: One Simple and One Not-So-Simple Case

Case #4: Left Main CTO in Cardiogenic Shock

Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection

Featured Trial of the Day: OPTIMIZE: A Prospective, Randomized Trial of Three Months vs. 12 Months of Dual Antiplatelet Therapy After PCI

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content